Skip to main content

Table 3 Side-effects following endobronchial infusion of the adipose derived stromal cells-stromal vascular fraction (ADSCs-SVF) in patients with IPF (n=14)

From: A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis

Side-effects Number of patients (%)
Fever 7 (50%)
Worsening of cough 2 (14%)
Worsening of dyspnea 2 (14%)
Oxygen desaturations 2 (14%)
Cardiac abnormalities 0
Allergic reactions 0
Infections 0
Liver abnormalities 0
Renal abnormalities 0
Acute exacerbation/Hospitalization 0
Deaths 0
Ectopic tissue formation (24 months follow-up) 0
  1. Abbreviations: IPF Idiopathic pulmonary fibrosis.